Your browser doesn't support javascript.
loading
Early tumour response as a survival predictor in previously- treated patients receiving triplet hepatic artery infusion and intravenous cetuximab for unresectable liver metastases from wild-type KRAS colorectal cancer.
Bouchahda, Mohamed; Boige, Valérie; Smith, Denis; Karaboué, Abdoulaye; Ducreux, Michel; Hebbar, Mohamed; Lepère, Céline; Focan, Christian; Guimbaud, Rosine; Innominato, Pasquale; Awad, Sameh; Carvalho, Carlos; Tumolo, Salvatore; Truant, Stephanie; De Baere, Thierry; Castaing, Denis; Rougier, Philippe; Morère, Jean-François; Taieb, Julien; Adam, René; Lévi, Francis.
Afiliação
  • Bouchahda M; AP-HP, Departments of Medical Oncology, Hepato-Biliary Surgery and Radiology, Paul Brousse Hospital, Villejuif, France; INSERM and Paris-Saclay UMR S935, CNRS Campus, Villejuif, France; Ramsay-GDS Mousseau Clinics, Evry, France.
  • Boige V; Gustave-Roussy Institut, Villejuif, France.
  • Smith D; Saint André Hospital, Bordeaux, France.
  • Karaboué A; INSERM and Paris-Saclay UMR S935, CNRS Campus, Villejuif, France; AK-SCIENCES, Research and Therapeutic Innovation, Vitry-Sur-Seine, France.
  • Ducreux M; Gustave-Roussy Institut, Villejuif, France.
  • Hebbar M; Medical Oncology Unit, Huriez Hospital, Lille, France.
  • Lepère C; Georges Pompidou European Hospital, Paris, France.
  • Focan C; CHC Saint Joseph Clinics, Liège, Belgium.
  • Guimbaud R; Digestive Medical Oncology Unit, Toulouse University Hospital, Toulouse, France.
  • Innominato P; AP-HP, Departments of Medical Oncology, Hepato-Biliary Surgery and Radiology, Paul Brousse Hospital, Villejuif, France; INSERM and Paris-Saclay UMR S935, CNRS Campus, Villejuif, France; Cancer Chronotherapy Unit, Warwick Medical School, Coventry, United Kingdom.
  • Awad S; AP-HP, Departments of Medical Oncology, Hepato-Biliary Surgery and Radiology, Paul Brousse Hospital, Villejuif, France.
  • Carvalho C; Medical Oncology Unit, Fernando Fonseca Hospital, Amadora, Portugal.
  • Tumolo S; Santa Maria Degli Angeli General Hospital, Pordenone, Italy.
  • Truant S; Medical Oncology Unit, Huriez Hospital, Lille, France.
  • De Baere T; Gustave-Roussy Institut, Villejuif, France.
  • Castaing D; AP-HP, Departments of Medical Oncology, Hepato-Biliary Surgery and Radiology, Paul Brousse Hospital, Villejuif, France.
  • Rougier P; Georges Pompidou European Hospital, Paris, France.
  • Morère JF; AP-HP, Departments of Medical Oncology, Hepato-Biliary Surgery and Radiology, Paul Brousse Hospital, Villejuif, France.
  • Taieb J; Georges Pompidou European Hospital, Paris, France.
  • Adam R; AP-HP, Departments of Medical Oncology, Hepato-Biliary Surgery and Radiology, Paul Brousse Hospital, Villejuif, France; INSERM and Paris-Saclay UMR S935, CNRS Campus, Villejuif, France.
  • Lévi F; AP-HP, Departments of Medical Oncology, Hepato-Biliary Surgery and Radiology, Paul Brousse Hospital, Villejuif, France; INSERM and Paris-Saclay UMR S935, CNRS Campus, Villejuif, France; Cancer Chronotherapy Unit, Warwick Medical School, Coventry, United Kingdom. Electronic address: F.Levi@warwick.ac
Eur J Cancer ; 68: 163-172, 2016 11.
Article em En | MEDLINE | ID: mdl-27768923

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Adenocarcinoma / Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias Hepáticas Idioma: En Ano de publicação: 2016 Tipo de documento: Article País de afiliação: França

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Adenocarcinoma / Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias Hepáticas Idioma: En Ano de publicação: 2016 Tipo de documento: Article País de afiliação: França